Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness.

Authors
Type
Published Article
Journal
SpringerPlus
2193-1801
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Volume
4
Pages
638–638
Identifiers
DOI: 10.1186/s40064-015-1441-5
PMID: 26543772
Source
Medline
Keywords
  • Dapsone
  • Erlotinib
  • Glioblastoma
  • Interleukin-8
  • Neutrophils
  • Non-Small Cell Lung Cancer
  • Ovarian Cancer
  • Pancreas Cancer
  • Quality Of Life
  • Rash

Abstract

Statistics

Seen <100 times